Kymera Therapeutics (KYMR) Q3 2025 Earnings

Aug 11Confirmed
Q4 2024
Q1 2025
Q2 2025
Q3 2025
-0.95
-0.89
-0.83
-0.77

Details

Expected EPS
-0.810038
Actual EPS
-0.95
Surprise EPS
-0.14
Surprise Percent
-17.28%

Description

⁨Kymera Therapeutics⁩ (⁦KYMR⁩) has reported earnings of ⁦-0.95⁩ per share for ⁦Q3 2025⁩.

0 Comments

Share your thoughts